Tax increase should have minimal impact on India's drug industry

03/3/2013 | Economic Times (India), The

Excise tax increases on drug imports to India should have little impact on the current robust growth of the Indian pharmaceutical industry, according to a report by global analytics company Crisil. The firm projects a domestic growth rate year-over-year increase of 16% to 17% through 2014, coupled with export increases of 17%, as India increasingly taps into generics and manufacturing opportunities for bulk drugs.

View Full Article in:

Economic Times (India), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ